Introduction
============

Fungal Infections and *Candida albicans*
----------------------------------------

One to five million fungal species are estimated to exist of which only 400--600 (\< 0.1%) are documented to be pathogenic to humans and of those only about 100 are commonly found as human pathogens ([@B181]; [@B19]; [@B42]; [@B94]; [@B87]). However, these fungal pathogens/infections are still often overlooked and underestimated even though they have evolved from uncommon to a major global health problem, paradoxically due to the introduction of new medical therapies ([@B24]; [@B94]; [@B48]). Recent outbreaks have drawn more attention to fungal infections ([@B13]). It is estimated that over a billion people are affected by superficial fungal infections and about 1.5 million people die due to invasive fungal diseases worldwide each year ([@B24]; [@B21]). Only a few classes of antifungals are available for the treatment of invasive infections and resistance is on the rise ([@B51]; [@B48]; [@B142]). These invasive fungal infections are associated with high mortality rates (up to 50%) and occur mainly in patients who had major surgery, are immunocompromised or on heavy antibiotic treatments. However, major infections in healthy individuals are increasing. The majority of those fungal-related deaths are attributed to only four genera of fungi: *Cryptococcus*, *Aspergillus*, *Pneumocystis*, and *Candida* ([@B173]; [@B24]; [@B48]). Specifically *Candida* infections are the 4th most common cause of hospital-acquired infections ([@B24]; [@B131]) and in the United States alone candidiasis is estimated to cost up to \$2--4 billion yearly ([@B191]). Within the genus *Candida*, *Candida albicans* is currently the most medically important species ([@B24]) but *Candida auris* is gaining a lot of recent publicity (see below).

*Candida albicans* is a pleiomorphic diploid fungus generally only found in humans. Up to 70% of humans are hosts of this fungus ([@B131]). It is generally considered as a commensal, but it can turn pathogenic in certain circumstances. These circumstances are often regarded as "caused" or provided by the host (e.g., being immunocompromised or taking antibiotic treatments) and not so much as actively generated by *C. albicans* itself ([@B94]; [@B119]; [@B131]). *C. albicans* can cause superficial mucosal infections such as oral thrush or vulvovaginal candidiasis but also life-threatening invasive infections ([@B173]; [@B24]; [@B94]; [@B131]). This switch from a commensal to a potentially lethal pathogen is still not fully understood ([@B131]). Recently, the 1st fungal cytolytic peptide toxin in *C. albicans*, candidalysin, was described and is thought to play a pivotal role in the pathogenicity of *C. albicans* ([@B119]; [@B123]). *C. albicans* can thrive in the human body. It is able to evade the immune system, colonize every organ and form biofilms on implanted medical devices ([@B24]; [@B117]; [@B131]; [@B164]). It is not surprising that it is used as a model organism to study fungal pathogenesis ([@B81]). *C. albicans* has a few remarkable characteristics that make it challenging to study. It is a diploid organism without a complete sexual cycle (no meiosis found so far) and has a non-canonical codon usage (CUG translated as serine rather than leucine), in addition, it lacks stable episomal plasmids and has a low transformation efficiency ([@B39]; [@B124]; [@B132]; [@B175]; [@B69]). In recent years, as novel research tools have been developed, the whole genome has been sequenced and the ORFs have been made available for the community in Gateway^TM^-adapted vectors ([@B80]; [@B86]; [@B125]; [@B103]).

One important feature to study in order to understand an organism is its protein-protein interactions (PPIs) ([@B8]; [@B41]; [@B90]). Advances in high-throughput detection techniques mean that mapping large physical PPI networks has become a possibility for several organisms ([@B8]; [@B158]; [@B188]; [@B41]), which will help in compiling the interactome of the studied organisms ([@B20]; [@B41]). Several techniques are available to study PPIs ([@B194]; [@B90]; [@B147]; [@B143]) but the most prominent techniques to study PPIs on a high-throughput scale are the tandem-affinity purification (TAP) followed by mass spectrometry ([@B59]; [@B96]; [@B41]) and the yeast two-hybrid (Y2H) assay ([@B188]; [@B41]; [@B207]). There are, however, about 25,000 CUG codons in *C. albicans*, complicating the use of *Saccharomyces cerevisiae* as a host organism to study *C. albicans* PPIs using the Y2H technique ([@B170]). A possible solution is to change the CUG codons ([@B72]; [@B9]) or work with only parts of the protein ([@B208]) to minimize translation problems, yet most researchers did not change the CUG codons when performing experiments in *S. cerevisiae* ([@B137], [@B138]; [@B27]). In one study, it was observed that changing the CUG codons led to the discovery of a PPI not found when using non-altered CUG codons ([@B53]). An adapted *Candida* two-hybrid (C2H) system was developed to overcome the problem with the non-canonical codon usage and the first small-scale high-throughput screen was performed with this system ([@B175]; [@B159]). The TAP-tag has also been used to study PPIs in *C. albicans*, but only a limited number of PPIs or complexes have been studied with this technique (see below).

Results
=======

Databases to Store PPI Data and Curation of the Literature Describing PPIs Demonstrated in *C. albicans*
--------------------------------------------------------------------------------------------------------

Several large-scale chromatin immunoprecipitation (ChiP) studies have already been done on *C. albicans* to study protein-DNA interactions, leading to several networks ([@B223]; [@B187]; [@B130]; [@B67]; [@B222]) and even leading to a few PPIs in *C. albicans* ([@B222]). However, limited by the difficulties encountered in *C. albicans* research ([@B132]; [@B139]) only a small number of PPIs have been detected in *C. albicans*. In contrast to the ChiP studies, no large scale high-throughput PPI screens have been performed for *C. albicans* and only a limited number of papers have described PPIs in *C. albicans* ([@B200]; [@B27]; [@B116]; [@B138]). Several (public) databases are available to screen for PPIs, but they are extremely limited when it comes to *C. albicans* PPIs. The Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) database does not even mention *C. albicans* ([@B180]) and the Database for Interacting Proteins (DIP) only holds a handful interactions ([@B155]). Another database, The Molecular INTeraction Database (MINT), only mentions 24 PPIs for *C. albicans* ([@B108]). The IntAct MINT mentions 25 interaction protein pairs ([@B89]). The Biological General Repository for Interaction Datasets (BioGRID) contained 188 PPIs extracted from 42 publications, release 3.4.156 (January 2018). These 188 interactions (using 139 unique genes) can further be divided into 128 unique protein interacting pairs (non-redundant interactions) ([@B27]; [@B138]). Because the BioGRID contains the largest number of PPIs for *C. albicans*, we decided to further continue our work with the BioGRID. A literature search revealed many PPIs that were not yet mentioned in this database. The absence of many interactions from the literature in the BioGRID (and other databases) also shows that PPI data are not generally sent to databases such as the BioGRID. A remarkable example is that the BioGRID database, release 3.4.156, mentioned only one interaction that was found with crystallography ([@B192]) while several structures of *C. albicans* proteins or enzymes showing PPIs have already been studied with crystallography ([@B204]; [@B161]; [@B47]; [@B122]; [@B145]; [@B66]; [@B157]; [@B3]; [@B150]; [@B126]; [@B163]; [@B211]; [@B127]; [@B184]; [@B71]; [@B169]; [@B46]; [@B57]; [@B91]) and mentioned in the protein data bank^[1](#footnote1){ref-type="fn"}^. A second observation during our literature search for PPIs in *C. albicans* is that certain "keywords" commonly used in papers studying PPIs are not often used by *C. albicans* researchers in their manuscripts.

To update the BioGRID with regard to *C. albicans* PPI data we performed an exhaustive literature search using several keywords ([Table 1](#T1){ref-type="table"}) in combination with "*C. albicans*" using Google search and PubMed. In addition to a literature search for novel PPIs we also checked the already available data for potential mistakes in order to correct them. All the novel interactions and/or mistakes in the already available data found during our literature search were sent to the BioGRID in order to update their data.

###### 

Keywords used to search PubMed and Google.

  --------------------------------
  Protein-protein interaction(s)
  TAP tag
  Co-IP
  Western blot
  Affinity purification
  FRET
  BRET
  Yeast two hybrid
  Y2H
  Protein interaction(s)
  Immunoprecipitation
  Crystal structure
  Physical interaction
  --------------------------------

Every keyword was used in combination with "

C. albicans

". E.g., "

C. albicans

Tap-tag" was used as a search term.

Putting PPIs in *C. albicans* in Perspective
--------------------------------------------

If one compares the data for *C. albicans* with the data available for *S. cerevisiae* (up to 171,000 non-unique interactions) ([@B194]; [@B138]) or certain bacteria ([@B140]; [@B198]; [@B138]), then it is easy to see that *C. albicans* PPI data are lagging behind significantly even though it is a highly studied organism. Another observation is that the golden standard reference website for the *Candida* community^[2](#footnote2){ref-type="fn"}^ ([@B170], [@B171]) does not have a direct link or a file to PPIs in *C. albicans* in contrast to the yeast genome database^[3](#footnote3){ref-type="fn"}^ that integrated, in a separate "tab", all the interactions for a protein of interest mentioned on the BioGRID ([@B32]). The combination "PPI" and "*C. albicans*" is also rarely used in the published literature ([Table 2](#T2){ref-type="table"}). This difference in found papers using the search term "PPI" and the name of the organism also shows that there is less work done regarding PPIs for *C. albicans* compared with the other four organisms ([Table 2](#T2){ref-type="table"}) and/or that *C. albicans* researchers are less inclined to use the term "PPIs" in their manuscripts. Four organisms were compared with *C. albicans*. *S. cerevisiae* and *Schizosaccharomyces pombe* were used since they are also yeast models. *Escherichia coli* is the bacterial "counterpart," serving as a model organism for bacteria while *Arabidopsis thaliana* is a plant model.

###### 

A search on pubmed (<https://www.ncbi.nlm.nih.gov/pubmed/>) using "PPIs" and the name of the organism resulted in X publications, while a search on the Biological General Repository for Interaction Datasets (<https://wiki.thebiogrid.org/doku.php/statistics>) shows how many PPIs are curated.

  **Searched keywords on PubMed**                **Results PubMed search**   **Non-redundant PPIs in BioGRID November 2018 ([@B27])**
  ---------------------------------------------- --------------------------- ----------------------------------------------------------
  Protein-protein interactions *C. albicans*     27 publications             611
  Protein-protein interactions *S. pombe*        106 publications            9575
  Protein-protein interactions *S. cerevisiae*   1714 publications           109 759
  Protein-protein interactions *E. coli*         1740 publications           12 801
  Protein-protein interactions *A. thaliana*     642 publications            35 897

The knowledge of PPIs is important for fully unraveling the complexity of organisms ([@B41]). Besides the importance of PPIs for the fundamental understanding of an organism, they also form potential targets for specific drugs ([@B90]; [@B12]; [@B129]). The latter is very important since finding novel drug targets is hard due to the similarities between the eukaryotic pathogen and the eukaryotic host ([@B76]). The currently limited availability of antifungals, rising resistance, and the increase of fungal infections underscore the need to identify new drug targets ([@B24]; [@B51]; [@B142]). PPIs might thus play an important role in the development of novel, very specific, antifungal drugs ([@B92]; [@B109]). An interesting example is blocking the interaction of Cdc42 with its CRIB-domain binding effectors and thereby inhibiting hyphal growth ([@B176]).

Several techniques have been used to detect the interactions described for *C. albicans*. The majority of them were found using affinity-capture techniques or by using the traditional Y2H technique as described below. The most important techniques used to study PPIs in *C. albicans* are described below.

Approaches to Study PPIs in *C. albicans*
-----------------------------------------

Several techniques are available to detect PPIs ([@B147]; [@B143]), but only a select few have been adapted for use in *C. albicans* ([@B23]; [@B175]; [@B139]; [@B177]). For a complete overview of all the used techniques and detected protein interactions in *C. albicans*, we refer to the BioGRID website^[4](#footnote4){ref-type="fn"}^ ([@B27]). So far, no large-scale or genome-wide screens have been performed, however, Prof. Whiteway's lab has performed two tandem affinity purifications (TAP) and detected more than 200 PPIs ([@B182], [@B183]). Prof. Liu's lab has also used a TAP approach to identify 103 interacting proteins for the Wor1 protein ([@B2]) while the labs of Profs. Emili, Gingras, and Cowen found more than 250 PPIs when studying Hsp90 ([@B134]). The labs of Profs. Dickman and Sudbery used the Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC) technique combined with mass-spectrometry (MS) and identified 126 interacting proteins for Cdc14 ([@B85]).

**Co-immunoprecipitation (Co-IP)** is a type of affinity purification technique that is referred to as "affinity-western" in the BioGRID database ([@B27]; [@B138]). Many of the studied interactions with the classic Co-IP technique were experiments to validate interactions found with other techniques such as the Y2H technique ([@B128]; [@B52]; [@B83]; [@B14]; [@B72]; [@B9]; [@B112]; [@B98]; [@B179]; [@B100]). An expert with this technology is Prof. Wang who has used Co-IP a lot in his lab and showed several interactions ([@B219], [@B220]; [@B105], [@B106], [@B104]; [@B168]; [@B11]; [@B217]; [@B195], [@B196]; [@B56]; [@B74], [@B75]; [@B64]; [@B7]; [@B110]; [@B214], [@B213]; [@B212]). Several tags have been used, such as a Flag-tag ([@B190]; [@B166]), Myc-tag ([@B29], [@B28]; [@B168]; [@B95]), GFP or derived tags ([@B15]; [@B62]), HA-tag ([@B128]; [@B6]; [@B160]), TAP-tag (see below) or the protein A tag with a TEV protease site ([@B18]). The Co-IP technique is rather limited and is not suited for high-throughput systems ([@B179]).

**Tandem-affinity purification** is another affinity purification technique that uses a TAP tag to perform a two-step specific affinity purification process. The original tag incorporated two protein A domains and the calmodulin binding peptide separated by a tobacco etch virus (TEV) protease site to provide the two-step affinity purification ([@B149]). Different versions of the TAP-tag were later designed without the TEV protease site ([@B209]). The TAP technique has the advantage that it can be used in a large-scale high-throughput setup where protein complexes are purified in two steps followed by protein identification with MS ([@B209]; [@B147]; [@B143]; [@B134]). It has, for example, been proven to be very efficient to perform large-scale screenings to identify PPIs and protein complexes in *S. cerevisiae* ([@B58]; [@B96]). A TAP tag was first successfully utilized in *C. albicans* by [@B82] to purify the *C. albicans* septin protein complex ([@B82]), which was later confirmed by another group ([@B168]). Both groups used a TAP-tagged Cdc11 protein and showed the same interactions except for two extra interactions found in the study from [@B168]. One of these interactions was the Gin4 protein shown to interact with Cdc11. The Cdc11-Gin4 interaction was interestingly reported to be detected only after a 150 min hyphal induction of the cells, but not after a 10 min induction ([@B168]). [@B82] did not find this interaction, but they only induced hyphal growth for 90 min ([@B82]), showing the need to induce hyphal growth long enough to have Gin4 interact with the septin complex. Later studies not using a TAP tag approach also demonstrated the interaction of Gin4 with members of the septin complex ([@B104]; [@B7]). The TAP-tag has also been applied to study several other complexes ([@B34]; [@B99]; [@B17]; [@B154]; [@B218]; [@B182], [@B183]; [@B64]; [@B101]; [@B146]; [@B2]). The mediator complex was studied twice ([@B218]; [@B182]) and both studies showed an overlap in found proteins (subunits) for the mediator complex, However, [@B182] found a total of 179 proteins interacting with Med7 while [@B218] tagged Med8 and used a pre-purification with heparin sepharose to bind the intact mediator complex followed by a TAP and only purified the 25 subunits of the mediator complex itself ([@B218]; [@B182]). Whether this difference is caused by the use of the pre-purification step is unclear. More recently [@B134] applied the TAP-tag to identify well over 250 PPIs.

The TAP-tags can also be used in a type of Co-IP experiment, tagging both the bait and prey constructs and not using an MS approach to identify the preys ([@B83]; [@B167]; [@B30]; [@B162]; [@B107]).

Using TAP-tag approaches with a two-step purification process has the advantage to produce cleaner protein samples for MS ([@B82]; [@B17]). However, single-step purification protocols followed by MS have also led to the discovery of several PPIs ([@B186]; [@B104]; [@B64]; [@B206]). Two of those studies used a GFP-tagged protein to purify the complexes ([@B104]; [@B64]) while [@B206] used a Flag-tagged Ydj1 protein ([@B206]). [@B186] used *E. coli*-expressed, His-tagged Cdc14 protein to pull down interacting proteins from a Cdc14 deletion mutant cell lysate ([@B186]). Proteins found in a single-step purification approach should be confirmed with another technique ([@B186]; [@B64]) as it often leads to false positives.

**SILAC** is a technique that takes advantage of the *in vivo* incorporation of non-radioactive isotope-labeled amino acids. It can be used to detect the up- or down-regulation of proteins. For this, growth medium is supplemented with a labeled amino acid that is then incorporated into the proteins of the cells grown on this medium ([@B135]). By subsequently mixing cells grown in this medium with cells grown in regular medium, lysing the cells, purifying the protein(s), and then digesting the purified proteins, the relative abundance of isotope-labeled and unlabeled proteins in the mixture can be determined by MS ([@B135]). In *C. albicans* the technique was first used in 2018 to perform a quantitative proteomic analysis of Cdc14 ([@B135]; [@B84]). Later the technique was used to study the proteome changes while transcriptionally repressing or pharmacologically inhibiting Hsp90 ([@B134]).

However, the technique can also be combined with an affinity purification step to identify PPIs. It was used to identify interacting proteins for Cdc14. This was achieved by growing a *C. albicans* strain with a phosphatase-dead, substrate-trapping Cdc14 protein with a Myc-tag (Cdc14^PD^-Myc, the "bait") on medium supplemented with heavy isotope-labeled arginine and lysine (heavy medium). In parallel, a wild-type strain was grown on light medium. After mixing the bait and wild-type strain in a 1:1 ratio, the cells are lysed and the bait was pulled down followed by SDS-page and trypsin digestion. In the subsequent MS analysis, Cdc14-specific interacting proteins showed a heavy-to-light (H:L) ratio greater than 1:1 because specific interacting proteins will originate from the heavy medium, whereas non-specifically bound proteins will have a 1:1 ratio. A total of 126 interacting proteins for Cdc14 could be detected. Remarkably, only a few of the found interactions have also been demonstrated for the orthologous proteins in *S. cerevisiae* ([@B85]). See also [Supplementary Tables S1](#TS1){ref-type="supplementary-material"}, [S2](#TS1){ref-type="supplementary-material"}.

The SILAC approach (combined with affinity-purification) has several advantages: (1) it can be used in a high-throughput setup, (2) there is no forced cell localization (e.g., two-hybrid techniques force proteins into the nucleus), and (3) post-translational modifications can be preserved. The SILAC technique is also quantitative and not qualitative as is the traditional TAP-tag approach. The samples in SILAC are also analyzed as a whole single sample, thus minimizing the bias in sample handling ([@B136]; [@B49]).

**Bimolecular Fluorescence Complementation (BiFC)** is a technique that can be used to study PPIs *in vivo* in their native environment and location ([@B88]) and is one of many protein complementation techniques (PCA) ([@B221]). Since its discovery, this technique has been applied in several organisms in a high-throughput setup ([@B118]). However, it proved difficult to apply this system in *C. albicans* and only recently it was used to detect several binary interactions ([@B115]; [@B177]). [@B177] worked with an overexpression plasmid system with the genes under the control of the *MET3* promoter rather than endogenously tagged proteins. [@B115] also used the *MET3* promoter, but were also able to use the native promoter for the Ftr1 and Fet34 BiFC constructs. Besides the need to codon-optimize the fluorophores (CUG codons), another potential explanation for the difficulties with adapting this system is the autofluorescence of *C. albicans* ([@B44]; [@B61]). In addition to BiFC, several other PCAs are used for the detection of PPIs e.g., the split luciferase system ([@B174]). However, so far, no other PCAs have been applied for PPI detection in *C. albicans* ([@B27]), despite the fact that several luciferases have been optimized for and used in *C. albicans*, for example, for the study of biofilm formation and drug susceptibility ([@B78]; [@B97]; [@B45]). A split luciferase system can thus potentially be developed for use in *C. albicans*. It is also possible to use fluorophores and luciferases in a Förster Resonance Energy Transfer (FRET) or Bioluminescence Resonance Energy Transfer (BRET) system, however, BRET has so far not been reported in *C. albicans* ([@B27]). A FRET biosensor has been shown to work in *C. albicans* ([@B79]) and *Candida glabrata* ([@B43]).

**The Vesicle Capture Interaction (VCI)** assay was developed for use in *C. albicans* to circumvent the codon usage problem when using the model organism *S. cerevisiae*. VCI can be used to detect binary interactions. The technique is based on the targeting to endocytic vesicles by the Endosomal Sorting Complex Required for Transport (ESCRT) of which Snf7 (Vps32) is a subunit. The technique uses a *vps4*Δ mutant strain that promotes vesicular accumulation of Snf7. A bait protein is fused to the ESCRT subunit Snf7 while the prey protein is fused to a GFP protein. When bait and prey interact, a punctate GFP signal can be detected compared with a diffuse signal if no interaction occurs. The technique uses the native promoters so overexpression is avoided and real-time imaging facilitates the detection of transient interactions. The system was, so far as we know, only used in two studies from the lab that developed it ([@B23]; [@B4]). It remains an open question how applicable it is on a high-throughput setup.

**The expanded genetic code system** is a technique adapted for use in *C. albicans*. It relies on the incorporation of a synthetic photo-cross-linker amino acid, p-azido-L-phenylalanine (AzF), in a "bait" protein to covalently capture the binding partner (prey) after UV-activation. To incorporate AzF into the protein of interest, an amber stop codon needs to be introduced into this protein in a *C. albicans* strain that expresses the optimized orthogonal tRNA and tRNA synthetase for AzF. It is at the amber stop codon where AzF, provided in the medium, is incorporated (rather than terminating the translation). So far, only two interactions, TUP1 and TSA1 have been studied using this technique ([@B139]). The technique has been proven to be valuable but has some limitations such as high dependence on the incorporation efficiency of AzF and the lack of site selectivity ([@B197]). The amounts of mutant protein is also reduced significantly compared with the wild-type ([@B139]). The technique is still relatively new, and given its complexity and high cost, it seems unlikely that it will be used in a high-throughput setup soon. So far, no other studies applying this technique have been reported in *C. albicans*.

**The Yeast two-hybrid (Y2H)** system has become, since the first publication, one of the most used systems to detect PPIs *in vivo* ([@B8]; [@B165]). Several adaptations have been created and the Y2H system has been used to perform large-scale or even genome-scale PPI assays for several organisms ([@B102]; [@B8]; [@B158]; [@B65]). Compared to another technique often used in high-throughput screenings, mass spectrometry (MS) of purified complexes, the Y2H technique is easier and cheaper to use ([@B194]; [@B25]; [@B165]) and multiple commercial plasmids and yeast strains are available. It however, suffers from large amounts of false positives and negatives. The system also forces proteins into the nucleus, making it hard to use for certain proteins (e.g., cell membrane components) ([@B189]; [@B165]). A potential solution for the problematic forced nuclear movement is the removal of parts of the protein of interest ([@B203]; [@B120]). Despite these problems, it is still one of the most used and best techniques for high-throughput screening of PPIs ([@B165]).

In *C. albicans*, in spite of the codon usage problem, the Y2H technique is still responsible for the discovery of a large fraction of PPIs ([@B27]). Most researchers used the traditional Y2H system to detect PPIs ([@B60]; [@B27]; [@B138]) but it is also possible to use an adapted Y2H system: the SRYTH (Ste11p/Ste50p Related Yeast Two-Hybrid) system, which allows cytoplasmic PPI analysis ([@B113]). This system makes use of the essential interaction of Ste11 and Ste50 to activate the high osmolarity glycerol (HOG) pathway in *S. cerevisiae*, in the absence of the SLN1--SSK1--SSK2/SSK22 pathway, in order to survive under osmotic stress ([@B205]; [@B113]). Ste11 and Ste50 interact with each other through their sterile alpha motif (SAM) domain. These SAM domains can, however, be replaced by two proteins of interest (bait and prey). If those proteins interact, then Ste11 and Ste50 are brought together, the HOG pathway is activated and the cells survive under osmotic stress ([@B205]; [@B113]). This system was used to study the mating pheromone pathway of *C. albicans* ([@B36]) and several transcription factors ([@B114]).

**The Candida two-hybrid (C2H)** system is a special adaptation of the Y2H system (see [Figure 1](#F1){ref-type="fig"}). It was designed in 2010 to address the codon usage problem in *S. cerevisiae*. Compared with the traditional Y2H system, it uses an integrative approach because plasmids are not very stable in *C. albicans*. Expression of the bait and prey constructs is driven by the *MET3* promoter and can be up-regulated by omitting methionine or both methionine and cysteine from the medium for a higher expression of the bait and prey constructs. With this system, several interactions were detected in a low-throughput setup ([@B175]). The system was later used to confirm the interaction between the MAP kinases Cek1 and Cek2 ([@B33]), an interaction that is remarkably not found with the SRYTH system ([@B36]). The C2H system was also used to validate the PPIs found with the BiFC assay ([@B177]). In the most recent paper using the C2H system, [@B201] tried to demonstrate the interaction between transcription factors Grf10 and Bas1 but without success ([@B201], [@B202]). The C2H system had been limited to small-scale studies until recently when it was adapted to a high-throughput setup ([@B103]; [@B159]).

![Schematic representation of the C2H system. **(A)** When no bait protein is attached to the DBD no interaction is possible and no transcription will take place. **(B)** Represents a situation in which no prey is attached to the AD leading to no transcription. In **(C)** both a prey and bait are present, but they do not interact so no transcription happens. Situation **(D)** depicts the interaction between a prey and bait protein thus leading to recruitment of RNA polymerase II and subsequent transcription. A common problem is the auto-activation by bait proteins. It is thus always essential to test auto-activation using the setup seen in part **B**.](fmicb-10-01792-g001){#F1}

The CTG clade of *Candida* includes nine potential pathogens ([@B55]). All of these can benefit from using the C2H system to study PPIs. One emerging pathogen in particular, *C. auris*, raises concerns due to its resistance against antifungals and sudden emergence ([@B111]). [Table 3](#T3){ref-type="table"} lists the CTG clade species, all of which can be studied with the C2H system.

###### 

Members of the CTG clade.

  **Species**                     
  ------------------------------- -----------------------------
  *Candida tenuis*                *Candida parapsilosis*
  *Candida auris*                 *Candida metapsilosis*
  *Candida lusitaniae*            *Candida orthopsilosis*
  *Metschnikowia fruticola 277*   *Candida sojae*
  *Candida fermentati*            *Candida tropicalis*
  *Candida guilliermondii*        *Candida dubliniensis*
  *Debaryomyces fabryi*           *Candida albicans*
  *Candida famata*                *Spathaspora passalidarum*
  *Scheffersomyces stipitis*      *Lodderomyces elongisporus*
  *Spathaspora arborariae*        

All of these species translate the CUG codon to serine rather than leucine (

Priest and Lorenz, 2015

;

Gabaldón et al., 2016

) and can thus use the C2H system to study PPIs.

Comparing Data Between *C. albicans* and *S. cerevisiae*
--------------------------------------------------------

*Saccharomyces cerevisiae* has been studied extensively regarding PPIs. Release 3.5.174, July 2019 from the BioGRID contains over 114,693 PPIs for *S. cerevisiae* while *C. albicans* only has 876 non-redundant interactions mentioned ([@B27]). While *S. cerevisiae* often functions as a model organism for fungi (in general) it is not always a good idea to extrapolate data from *S. cerevisiae* to *C. albicans*. While many pathways perform similar cellular functions, differences are also present, making it harder to simply extrapolate data from *S. cerevisiae* to construct pathways in *C. albicans* ([@B93]; [@B153], [@B152]; [@B10]; [@B16]; [@B29]; [@B40]; [@B172]). Interestingly, of the 1,208 non-redundant PPIs in *C. albicans* (see [Supplementary Tables S1](#TS1){ref-type="supplementary-material"}, [S2](#TS1){ref-type="supplementary-material"}, based on release 3.5.174 from BioGRID and our literature search), we were able to find only 249 PPIs that were also demonstrated in *S. cerevisiae*. Several of the PPIs identified using Mcu1 and Snf6 as bait in *C. albicans* were not found in *S. cerevisiae* as it does not have orthologs of the two proteins according to the CGD database (based on BLAST analysis: query coverage of 13% between *Ca*Snf6 and *Sc*Snf6). Snf6 was however, identified as a member of the SWI/SNF complex and it was shown that the N-terminal domain, which interacts with Snf2, is conserved in *S. cerevisiae* ([@B183]); in addition, although Wor1, Hsp90, Med7, and Cdc14 together have over 500 interacting proteins in *C. albicans*, only a few of these interactions can be found with *S. cerevisiae* orthologs ([Supplementary Tables S1](#TS1){ref-type="supplementary-material"}, [S2](#TS1){ref-type="supplementary-material"}). The low overlap of PPIs between orthologs in *C. albicans* and *S. cerevisiae* might indicate big differences in PPIs and protein functions between the two organisms. This is no surprise given that *C. albicans* co-evolved with its host, being a commensal and potential pathogen, whereas *S. cerevisiae* is a saprophyte and only occasionally becomes pathogenic to humans. The two fungi are evolutionarily separated for 140--850 millions years ([@B93]; [@B16]; [@B170]) and only approximately 55% of the genes in both organisms have orthologs (we only looked at orthologous genes and not "best hits") ([@B170]). An important remark is that while in *S. cerevisiae* many interactions are studied with multiple techniques, this is not the case for *C. albicans*. Using different techniques is crucial to confirm PPIs ([@B194]; [@B216]) so perhaps the low overlap is also partly due to the limited number of techniques used for detection of PPIs in *C. albicans* (see [Supplementary Tables S1](#TS1){ref-type="supplementary-material"}, [S2](#TS1){ref-type="supplementary-material"}).

An interesting, but often overlooked, dataset comprises the data of PPIs that were tested but could not be demonstrated as they are often not mentioned in the published literature. To further look into the differences between PPIs in *C. albicans* and *S. cerevisiae*, we also looked into the literature for PPIs that were investigated but not demonstrated for *C. albicans*. We then also compared this with known data in *S. cerevisiae*. With this information, we were able to construct [Table 4](#T4){ref-type="table"}. Our lab currently also hosts a more extensive and up-to-date list of interactions tested but not detected in *C. albicans* at: <https://docs.google.com/spreadsheets/d/1nZDAPyyfCaqqtvAkU_Xt8wZcOPK6-17jJxQxKSen58g/edit#gid=93661881>.

###### 

A (limited) set of PPIs mentioned in several papers that could not be detected for *C. albicans* proteins.

  ***C. albicans ([@B138])***   ***S. cerevisiae (with orthologs) ([@B32])***                                     
  ----------------------------- ----------------------------------------------- --------------------------- ----- -----
  Far1                          Ste11                                           Cyt. Y2H ([@B36])           No    No
  Far1                          Ste11                                           Co-IP ([@B215])             "     "
  Far1                          Hst7                                            Cyt. Y2H ([@B36])           No    No
  Far1                          Hst7                                            Co-IP ([@B215])             "     "
  Far1                          Cek1                                            Cyt. Y2H ([@B36])           No    Yes
  Far1                          Cek1                                            Co-IP ([@B215])             "     "
  Far1                          Cek2                                            Cyt. Y2H ([@B36])           No    Yes
  Far1                          Cek2                                            Co-IP ([@B215])             "     "
  Cst5^∗^                       Cek2^\*^                                        Cyt. Y2H ([@B36])           Yes   Yes
  Ste11                         Far1                                            Cyt. Y2H ([@B36])           No    No
  "                             Ste11                                           Cyt. Y2H ([@B36])           Yes   Yes
  "                             Cek2                                            Cyt. Y2H ([@B36])           Yes   Yes
  Hst7                          Far1                                            Cyt. Y2H ([@B36])           No    No
  Hst7                          Hst7                                            Cyt. Y2H ([@B36])           Yes   Yes
  Hst7^∗∗^                      Cek1^∗∗^                                        Cyt. Y2H ([@B36])           Yes   Yes
  Hst7                          Cek2                                            Cyt. Y2H ([@B36])           "     "
  Hst7                          Cek2                                            C2H ([@B175])               "     "
  Cek1                          Far1                                            Cyt. Y2H ([@B36])           No    Yes
  Cek1°                         Hst7°                                           Cyt. Y2H ([@B36])           No    Yes
  "                             Cek1                                            Cyt. Y2H ([@B36])           No    Yes
  "                             Cek2                                            Cyt. Y2H ([@B36])           No    Yes
  "                             "                                               C2H ([@B175])               "     "
  Cek2                          Far1                                            Cyt. Y2H ([@B36])           No    Yes
  Cek2                          Cst5                                            Cyt. Y2H ([@B36])           No    Yes
  "                             Ste11                                           Cyt. Y2H ([@B36])           Yes   Yes
  Cek2                          Hst7                                            Cyt. Y2H ([@B36])           Yes   Yes
  Cek2                          Hst7                                            C2H ([@B175])               "     "
  Cek2                          Hst7                                            Y2H ([@B31])                      
  Cek2°                         Cek1°                                           Cyt. Y2H ([@B36])           No    No
  "                             Cek2                                            Cyt. Y2H ([@B36])           No    Yes
  Gin4                          Cdc24                                           Co-IP ([@B104])             No    No
  "                             Cdc42                                           Co-IP ([@B104])             No    No
  "                             Cla4                                            Co-IP ([@B104])             No    No
  Rpp2A                         Rpp2A                                           Y2H ([@B1])                 No    Yes
  "                             Rpp2B                                           Y2H ([@B1])                 No    Yes
  Rpp2B                         Rpp2A                                           Y2H ([@B1])                 Yes   Yes
  "                             Rpp2B                                           Y2H ([@B1])                 No    Yes
  Cgt1                          Cgt1                                            Y2H ([@B210])               No    No
  Ras2                          Cyr1 (RA-domain)                                Y2H ([@B52])                No    Yes
  Ras1                          Cyr1                                            Aff C-MS ([@B199])          No    No
  Ras1                          Cyr1                                            Aff C-MS ([@B224])          No    No
  Hsp90§                        Crk1                                            Y2H ([@B128])               No    No
  Hsp90§                        Sti1                                            Y2H ([@B128])               Yes   Yes
  Hsp90§                        Cdc37                                           Y2H ([@B128])               Yes   Yes
  Vrp1                          Hof1                                            Y2H ([@B22])                Yes   Yes
  Opi1                          Ino2                                            GST pulldown ([@B72])       Yes   Yes
  Opi1                          Ino4                                            GST pulldown ([@B72])       Yes   Yes
  Opi1                          Sin3                                            Y2H/GST pulldown ([@B68])   Yes   Yes
  Far1\^                        Tpk1\^                                          Co-IP ([@B215])             No    No
  Cst5\^                        Tpk1\^                                          Co-IP ([@B215])             No    No
  Bas1                          Gfr10                                           C2H ([@B201])               Yes   Yes
  Gfr10                         Bas1                                            C2H ([@B201])               Yes   Yes
  Swi6                          Nrm1                                            Co-IP ([@B133])             /     /

∧

Are two interactions not expected to occur, they were used as negative controls.

\*

Shows an interaction that was shown by

Yi et al. (2011)

with a Co-IP.

∗∗

Interaction demonstrated by

Legrand et al. (2018)

and

Stynen et al. (2010)

. ° Interaction demonstrated by

Stynen et al. (2010)

. §  It is not certain whether Hsp90 was used as a bait or prey construct (

Ni et al., 2004

). Cyt. Y2H = cytoplasmic Y2H. For Cek2 we used the "best hit" protein ScFus3 to compare the data from

C. albicans

with

S. cerevisiae

.

Apart from helping elucidate differences between two organisms, the "non-interacting" protein pairs might also indicate which technique could be used to study certain proteins or interactions.

Case Study Regarding PPIs Shown in *C. albicans*
------------------------------------------------

The cell wall is a dynamic structure that offers a first line of defense against external influences. As *C. albicans* can be present in any host niche, it must have a huge range of possible adaptations to external stresses ([@B50]; [@B151]). Several pathways have been documented that play a role in these adaptation processes. Four of the most studied and important pathways are depicted in a simplified version in [Figure 2](#F2){ref-type="fig"}. The cAMP-PKA pathway acts through a Ras1-independent or -dependent mechanism as a response to several external influences such as the quorum-sensing molecules homoserine lactone (HSL) and farnesol, amino acids, CO~2~, serum, *N*-acetylglucosamine (GlcNac) or glucose. The HOG pathway is important to react upon osmotic and oxidative stress while the cell wall integrity (PKC) and Cek1-mediated (or SVG) pathways play a role in the response toward cell wall damage and stress. All four pathways play a crucial role in morphogenesis and the survival of *C. albicans* under stress conditions ([@B16]; [@B40]; [@B131]). While there is considerable knowledge regarding how the pathways function in *C. albicans*, there is still a lot to demonstrate in terms of PPIs. [Figure 2](#F2){ref-type="fig"}, for example, shows that only 8 out of the 26 depicted potential PPIs have been demonstrated in *C. albicans* ([@B27]). A ninth PPI that could be shown in [Figure 2](#F2){ref-type="fig"} is the direct interaction between Msb2 and Cst20 ([@B193]). In *S. cerevisiae* all interactions for the depicted pathways in [Figure 2](#F2){ref-type="fig"} have already been demonstrated ([@B32]).

![Basic schematic representation of the cAMP-PKA pathway (green) and three MAPK pathways in *Candida albicans* which are important for morphogenesis, adaptation to stress and survival. The cell integrity pathway (also known as PKC pathway) is depicted in orange, the HOG pathway is shown in blue and the CEK1 mediated pathway (also known as SVG pathway) is represented in purple. Pathways depicted here are an oversimplified version. A direct interaction between Msb2 and Cst20 ([@B193]) is for example not depicted here. For a more in depth overview see Refs. ([@B16]; [@B40]; [@B178]; [@B73]; [@B131]; [@B26]). Notice also the arrow between Ste11 and Pbs2. In yeast the Sho1 branch plays a role in osmotic stress signaling to Hog1 ([@B70]). However, in *C. albicans* this does not seem to be the case as Ssk2 is the only MAPKKK signaling to Hog1 ([@B29]; [@B152]). Arrows in green depict physical interactions between two proteins that have already been demonstrated in *C. albicans*. Arrows in black are Protein-protein interactions not yet demonstrated in *C. albicans*. See text for more details.](fmicb-10-01792-g002){#F2}

Conclusion
==========

Of the plethora of available techniques to study PPIs, only a select few have been used intensively for large-scale high-throughput screenings. Two of the most important techniques are the TAP-MS and Y2H system ([@B41]; [@B143]). Both techniques have been used to examine a large number of PPIs for several organisms, leading to a profound knowledge on the studied organisms and even the start of the construction of the interactome of the studied organisms ([@B77]; [@B194]). PPI studies in *C. albicans* are, however, lagging behind. *C. albicans* is comparable with *S. cerevisiae* in terms of ORFs, respectively, 6,198 vs. 6,572. Both organisms serve as model organisms and are fully sequenced. However, a staggering 70% of the ORFs are still not characterized in *C. albicans* versus 12% in *S. cerevisiae* ([@B32]; [@B170]). Looking at PPIs the difference is even more extreme (based on release 3.5.174, July 2019); 1,080 interactions for *C. albicans* are mentioned in the BioGRID vs. 171,959 for *S. cerevisiae* ([@B27]; [@B138]). [Supplementary Tables S1](#TS1){ref-type="supplementary-material"}, [S2](#TS1){ref-type="supplementary-material"} give an overview of interactions found in *C. albicans* that also have been detected in *S. cerevisiae* using orthologs. [Supplementary Table S2](#TS1){ref-type="supplementary-material"} also shows that the majority of PPIs shown in *C. albicans* have been demonstrated with only one technique while in *S. cerevisiae* the majority of PPI have been demonstrated using multiple techniques. Interactions should, ideally, always be validated with two or more techniques ([@B8]; [@B58]; [@B194]). Despite being one of the first fully sequenced fungal pathogens ([@B80]), the difficulties encountered when working with *C. albicans* have slowed down the progress ([@B132]). This is mainly due to the non-canonical codon usage in *C. albicans* and the long-held misconception that the gene function of *C. albicans* is very similar to that of *S. cerevisiae*. The latter has, however, been shown to be more complicated ([@B23]). Until now, only 249 out of a total of 1,208 non-redundant PPIs in *C. albicans* have also been demonstrated in *S. cerevisiae* (see also [Supplementary Tables S1](#TS1){ref-type="supplementary-material"}, [S2](#TS1){ref-type="supplementary-material"}). A critical note here is that our tables also contain PPIs demonstrated in other *C. albicans* strains than the wild type-strain SC5314 (or its derivative strains) and PPIs deposited at the rcsb protein structure database, but not yet published.

Knowing that a similar organism, *S. cerevisiae*, has an estimated total of 30,000 to 40,000 interactions ([@B63]; [@B156]) or even more ([@B65]), there is still a lot to discover for *C. albicans*. Besides giving fundamental knowledge, PPIs can also be used as very specific drug targets ([@B90]). Previously thought undruggable, PPIs have become increasingly interesting targets for drug development ([@B121]). Given the limited availability of antifungals, rising resistance, lack of antifungal vaccines, difficulties in antifungal drug development, and the increase of fungal infections worldwide ([@B24]; [@B51], Fairlamb et al., 2017; [@B141]) PPIs might become crucial in the future development of novel, specific antifungals.

In the "omics" era, the enormous amount of information generated by a wide range of large-scale, high-throughput assays creates severe problems for data storage and sorting, which emphasizes the importance of data collection and curation ([@B35]; [@B148]). Open databases such as the *Candida* genome database (CGD) ([@B170]) and the BioGRID ([@B137], [@B138]; [@B27]) are crucial tools for *Candida* researchers. Integration of the BioGRID PPI dataset into the CGD would be a substantial improvement of the CGD. Currently the CGD only mentions the BioGRID as an external link on the summary page of the genes.

While using PPI data from *S. cerevisiae* to aid in constructing *C. albicans* PPI networks, caution is advised considering the low overlap between the PPI data ([Supplementary Tables S1](#TS1){ref-type="supplementary-material"}, [S2](#TS1){ref-type="supplementary-material"}). [@B38], for example, constructed a PPI network with a focus on proteins important for hyphae formation in *C. albicans* using data from *S. cerevisiae*, a species generally regarded as only forming pseudohyphae, as a control for the validation of interactions ([@B5]; [@B38]). Comprehensive, high-quality databases of *C. albcians* genome sequences and PPIs will make it possible to resolve the *C. albicans* interactome based on *C. albicans* data rather than inferences from data obtained in *S. cerevisiae* ([@B54]; [@B185]; [@B200]; [@B116]; [@B38]). PPI databases, such as the BioGRID, play a crucial role in elucidating the protein interaction networks but also rely on external help to grow and keep up with the most recent research (the BioGRID relies on researchers to send in their data as it does not actively track PPI data from *C. albicans*). The latter was noticeable by the absence of a huge number of interactions in the BioGRID at the start of this review (compare releases 3.4.156 and 3.5.174), yet it is of the utmost importance for researchers to send in their data as the whole research community depends on such databases to perform their experiments with a high-quality dataset ([@B35]; [@B37]; [@B137]).

With an exhaustive literature search, we tried to include most of the PPIs known in *C. albicans* in the BioGRID dataset but are aware that some might still be missing. We therefore hope that future studies on PPIs in *C. albicans* will be sent to databases such as the BioGRID (an excel template for submitting PPI data can be found here^[5](#footnote5){ref-type="fn"}^) so that a more complete overview regarding PPIs can be achieved for *C. albicans*.
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